Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback
Option Care Health shares rose nearly 10% to $35.16 Tuesday after the company released preliminary Q4 results and doubled its share buyback authorization to $1.0 billion. The company projects Q4 net revenue of $1.46–$1.47 billion and adjusted EPS of $0.46–$0.49. A Citizens analyst raised the price target to $38, citing easing Stelara-related risk after 2026.